LEXXW vs NVR · rev $705.9K vs P/E 15, rev $4.21B
Lexaria Bioscience Corp (LEXXW) versus NVR Inc (NVR) — a side-by-side from cached financials, not a winner call.
Lexaria Bioscience Corp (LEXXW) common stock listed on US.
NVR Inc (NVR) is a residential construction company listed on NYSE.
Latest reported LEXXW revenue for 2025-08-31 was $705.9K. Net income was -$11.9M. Revenue was up 52.0% from 2024-08-31 to 2025-08-31. LEXXW currently screens at market cap $33.8M.
Latest reported NVR revenue for 2026-06-30 was $4.21B. Net income was $434.8M. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
LEXXW currently screens at market cap $33.8M. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
Not investment advice. Open the LEXXW and NVR stock pages for the full models.
Not investment advice.